Cannabis at Work: Testing Rules, Rescheduling, and Safety
Thank you for attending DISA's 2026 Screening, Safety, & Strategy Conference! The presentation and full audio recording are below.
Note: Click play on the video player, and then switch to the slides at the bottom right of the player window to follow along.
Use the arrow keys on your keyboard to navigate through the presentation.
Cannabis at Work: Testing Rules, Rescheduling, and Safety
Marijuana rules keep shifting across states while federal rescheduling remains in play. This session maps what matters for programs: THC vs CBD and hemp derivatives, impairment vs presence, and DOT vs non-DOT differences. Coverage includes test matrices and detection windows, panel and cutoff strategy, confirmation workflows, and MRO considerations, as well as policy considerations for safety-sensitive roles, accommodation touch points, and manager messaging.
Key Learnings:
- Regulatory and policy snapshot. State trends, federal rescheduling steps, DOT and non-DOT contrasts.
- Testing realities. Method and matrix differences, detection windows, delta-8 and other hemp variants, confirmation and cutoff choices.
- Program implications. Safety-sensitive focus, accommodation and discipline touch points, policy language, and documentation.